Is withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death.
about
Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial.Improving osteoporosis care in high-risk home health patients through a high-intensity interventionMultimodal intervention to improve osteoporosis care in home health settings: results from a cluster randomized trialWrist Fracture and Risk of Subsequent Fracture: Findings from the Women's Health Initiative Study.Clinical effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: population-based longitudinal study.Management of osteoporosis among the elderly with other chronic medical conditionsCommentary: the five Ws of a Fracture Liaison Service: why, who, what, where, and how? In osteoporosis, we reap what we sow.Anti-Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time-Series Analysis.Death, debility, and destitution following hip fracture.Hip fracture management for the hospital-based clinician: a review of the evidence and best practices.Minor, major, low-trauma, and high-trauma fractures: what are the subsequent fracture risks and how do they vary?Surgeons save bones: an algorithm for orthopedic surgeons managing secondary fracture prevention.Fractures and mortality in relation to different osteoporosis treatments.[Osteoporosis: therapy in interface management].The risk of major and any (non-hip) fragility fracture after hip fracture in the United Kingdom: 2000-2010.Consensus statement: osteoporosis prevention and treatment in Latin America-current structure and future directions
P2860
Q30652322-473DCA12-341F-4709-BE4F-5E68BAB4D75EQ33710755-56DF577E-0451-4815-842E-E57426D48E46Q33874008-E01DCB1D-6111-4E6A-A336-DDA64E07613BQ36190846-FC44FD24-6E99-47A0-9203-1BA9A2ED79FFQ36646998-FA1D2726-F70D-4CDE-A792-41FC847BF824Q37156112-2CE930E1-AF10-433D-B7E6-C00A0500605DQ37358202-9E5CE2EF-C82D-45E8-92C1-7B65A12F9B8FQ37437745-BD9D2845-205F-4882-BB0D-BB598F19A6AEQ37685432-DA9E287B-8DE4-4B5D-A453-8805572AA406Q37858368-60BECBA4-2914-4A80-B19D-27D353FD400EQ37893523-F982A8F2-D5DE-49B4-9591-67DCC9F86BC5Q38107423-0C2A8D22-8656-4FF4-BC19-4C43646657A7Q43577539-B160DE4A-A6C6-4E3C-A918-7AD9C3103B1CQ45801957-E0B2E50F-D8EA-4DEE-9824-F9F552C3CD66Q51129452-4D32EBE9-70DD-42C0-9C5F-55D2FAEA5FA5Q57167564-0BFFE407-ECF5-459E-BC7D-B23AAFF717E0
P2860
Is withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Is withholding osteoporosis me ...... second fracture versus death.
@ast
Is withholding osteoporosis me ...... second fracture versus death.
@en
Is withholding osteoporosis me ...... second fracture versus death.
@nl
type
label
Is withholding osteoporosis me ...... second fracture versus death.
@ast
Is withholding osteoporosis me ...... second fracture versus death.
@en
Is withholding osteoporosis me ...... second fracture versus death.
@nl
prefLabel
Is withholding osteoporosis me ...... second fracture versus death.
@ast
Is withholding osteoporosis me ...... second fracture versus death.
@en
Is withholding osteoporosis me ...... second fracture versus death.
@nl
P2093
P2860
P1476
Is withholding osteoporosis me ...... second fracture versus death.
@en
P2093
Allison Taylor
Amy Warriner
Cathleen Colon-Emeric
David J Becker
Elizabeth Delzell
Jeffrey R Curtis
Kenneth G Saag
Meredith L Kilgore
Michael A Morrisey
Robert S Matthews
P2860
P304
P356
10.1016/J.JAMDA.2009.12.004
P577
2010-06-30T00:00:00Z